Insight and Intelligence on the London & International Insurance Markets 19 Feb 2018

To view the full Insurance Insider site click here

D&O excess insurers in Pfizer claim dispute

  • John Hewitt Jones 1 February 2018
  • Arch Insurance and US Specialty Insurance Company (SIC) are seeking a judgment from the court of New Jersey to confirm they do not have to pay out for historic multi-million-dollar shareholder actions against pharmaceutical giant Pfizer.

    According to court documents, the two carriers provided Pfizer with excess-of-loss (XoL) insurance for side A and side B directors' and officers' (D&O) towers covering the 2004-2005 policy year.

    Pfizer has sought to claim on the policy in connection with a securities class action...

  • If you are a non-subscriber but would like to be able to view this article, then please go to our Publications page for further information on joining our readership
  • Login Free trial
  • Login